Hemiasterlin

哈米特林

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameHemiasterlin
Drug Alias NameER-807974E-7974
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsMitosis inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursUterine Cervical Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A